First reported in 2013, dominant mutations in GNAO1 cause a spectrum of early-onset neurological deficiencies in affected children, encompassing, depending on the exact mutation, severe motor disabilities, epileptic seizures, developmental delay, intellectual disability, and progressive brain atrophy [1–4]. The gene discussed is GNAO1; the disease is Global developmental delay.